StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30100% above fair value
$121.86−1.02 (-0.83%)

Close on Nov 17, 2026Market cap $26.73BP/E –Yield –

Insmed cash

Cash and short-term investments held at the end of each period.

Insmed's cash was $1.15B at Sep 30, 2026. For fiscal 2025 it was $1.43B, down 0.3% from the year before. Over ten years it grew 17.6% a year on average. The highest annual figure on record is $1.43B in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.43B-0.3%
FY2024Dec 31, 2024$1.43B+83.7%
FY2023Dec 31, 2023$780.45M-32.0%
FY2022Dec 31, 2022$1.15B+60.2%
FY2021Dec 31, 2021$716.78M+34.5%
FY2020Dec 31, 2020$532.76M+9.3%
FY2019Dec 31, 2019$487.43M-1.5%
FY2018Dec 31, 2018$495.07M+29.9%
FY2017Dec 31, 2017$381.17M+134.4%
FY2016Dec 31, 2016$162.59M-42.5%
FY2015Dec 31, 2015$282.88M+77.7%
FY2014Dec 31, 2014$159.23M+39.8%
FY2013Dec 31, 2013$113.89M+25.5%
FY2012Dec 31, 2012$90.78M+19.0%
FY2011Dec 31, 2011$76.27M-29.4%
FY2010Dec 31, 2010$108.05M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.15B-31.7%
Q2 FY2026Jun 30, 2026$1.16B-37.5%
Q1 FY2026Mar 31, 2026$1.22B+2.0%
Q4 FY2025Dec 31, 2025$1.43B-0.3%
Q3 FY2025Sep 30, 2025$1.68B+14.4%
Q2 FY2025Jun 30, 2025$1.86B+48.9%
Q1 FY2025Mar 31, 2025$1.20B+101.3%
Q4 FY2024Dec 31, 2024$1.43B+83.7%
Q3 FY2024Sep 30, 2024$1.47B+86.8%
Q2 FY2024Jun 30, 2024$1.25B+35.9%
Q1 FY2024Mar 31, 2024$595.73M-40.3%
Q4 FY2023Dec 31, 2023$780.45M-32.0%
Q3 FY2023Sep 30, 2023$785.95M+53.1%
Q2 FY2023Jun 30, 2023$917.77M+65.4%
Q1 FY2023Mar 31, 2023$998.68M+57.2%
Q4 FY2022Dec 31, 2022$1.15B+60.2%
Q3 FY2022Sep 30, 2022$513.30M-39.4%
Q2 FY2022Jun 30, 2022$554.87M-40.2%
Q1 FY2022Mar 31, 2022$635.12M+55.0%
Q4 FY2021Dec 31, 2021$716.78M+34.5%
Q3 FY2021Sep 30, 2021$846.56M+43.8%
Q2 FY2021Jun 30, 2021$928.33M+44.6%
Q1 FY2021Mar 31, 2021$409.75M-4.5%
Q4 FY2020Dec 31, 2020$532.76M+9.3%
Q3 FY2020Sep 30, 2020$588.75M+9.9%
Q2 FY2020Jun 30, 2020$641.91M+6.8%
Q1 FY2020Mar 31, 2020$428.94M+2.1%
Q4 FY2019Dec 31, 2019$487.43M-1.5%
Q3 FY2019Sep 30, 2019$535.63M-5.6%
Q2 FY2019Jun 30, 2019$601.26M-5.2%
Q1 FY2019Mar 31, 2019$420.23M-38.8%
Q4 FY2018Dec 31, 2018$495.07M+29.9%
Q3 FY2018Sep 30, 2018$567.57M+31.8%
Q2 FY2018Jun 30, 2018$634.33M+596.6%
Q1 FY2018Mar 31, 2018$686.58M+445.6%
Q4 FY2017Dec 31, 2017$381.17M+134.4%
Q3 FY2017Sep 30, 2017$430.68M–
Q2 FY2017Jun 30, 2017$91.06M–
Q1 FY2017Mar 31, 2017$125.84M–
Q4 FY2016Dec 31, 2016$162.59M–

More Insmed figures

See a number that looks wrong?